Insiders Trades
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (25 ops.)
Latest filing published 16 Oct 2026 for Gilead Sciences, INC., €418k. Read the official filing
Filing timeline
BuySaleAndrew D. Dickinson
Insider track record
Disclosed buys
0
Disclosed sells
25
Signal history
Andrew D. Dickinson: trading record in brief
Andrew D. Dickinson, listed as finance chief, appears in our data through filings on Gilead Sciences, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 10 June 2021 to 15 October 2026, the count stands at 64 filings.
No open-market purchase appears, only 25 sales worth €7.8M. No amount is published for 1 filing, which the totals therefore leave out. The rest of the record consists of 11 share grants and 28 option exercises. In 2026 alone, the filings show no purchases and 9 sales.
The latest filing, published on 16 October 2026, reports an open-market sale of €418k in Gilead Sciences, Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew D. Dickinson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations64 total
3,000 shares@ US$156.22Common StockSEC:0001310204-26-000031:0
3,000 shares@ US$145.290.0002% mcap2.4% of flowCommon StockSEC:0001310204-26-000029:0
2,797 sharesCommon StockSEC:0001310204-26-000027:0
1,347 shares@ US$144.810.0001% mcap1.1% of flowCommon StockSEC:0001310204-26-000027:1
3,000 shares@ US$138.360.0002% mcap2.3% of flowCommon StockSEC:0001310204-26-000024:0
3,000 shares@ US$129.92560.0002% mcap2.2% of flowCommon StockSEC:0001310204-26-000022:0
3,000 sharesCommon StockSEC:0001310204-26-000020:0
2,796 sharesCommon StockSEC:0001310204-26-000018:0
1,341 sharesCommon StockSEC:0001310204-26-000018:1
3,000 shares@ US$140.960.0002% mcap2.3% of flowCommon StockSEC:0001310204-26-000014:0
3,000 shares@ US$144.230.0002% mcap2.5% of flowCommon StockSEC:0001310204-26-000012:0
6,469 sharesCommon StockSEC:0001310204-26-000010:0
11,090 shares0Common StockSEC:0001310204-26-000008:0
3,000 shares@ US$154.430.0002% mcap2.5% of flowCommon StockSEC:0001310204-26-000006:0
44,867 shares0Common StockSEC:0001310204-26-000004:0
3,000 shares@ US$124.310.0002% mcap2.1% of flowCommon StockSEC:0001310204-26-000002:0
3,000 shares@ US$122.000.0002% mcap2.0% of flowCommon StockSEC:0001310204-25-000021:0
3,693 sharesCommon StockSEC:0001310204-25-000019:0
2,500 shares@ US$125.231.7% of flowCommon StockSEC:0001310204-25-000017:0
2,500 shares@ US$118.080.0002% mcap1.6% of flowCommon StockSEC:0001310204-25-000014:0
2,500 shares@ US$113.570.0002% mcap1.6% of flowCommon StockSEC:0001310204-25-000011:0
3,696 sharesCommon StockSEC:0001310204-25-000007:0
2,500 shares@ US$118.530.0002% mcap1.6% of flowCommon StockSEC:0001310204-25-000005:0
2,500 shares@ US$111.031.5% of flowCommon StockSEC:0001127602-25-019286:0
2,500 shares@ US$110.171.5% of flowCommon StockSEC:0001127602-25-017692:0
25 of 64 declarations
